Biogen shares hit by key Alzheimer’s drug concerns
February 15, 2018Research and Development Alzheimer's, Biogen, MSD, Merck, biotech, drugs, pharma, pharmaceutical
Biogen made investors very nervous after it announced that it was choosing to add an additional 510 patients to its …
Celltrion’s Herceptin biosimilar seals EU approval
February 15, 2018Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma
Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …
J&J’s apalutamide scores snap FDA approval in castration-resistant prostate cancer subgroup
February 15, 2018Sales and Marketing Cancer, Erleada, FDA, J&J, JJ, Johsnon & Johnson, apalutamide, pharma, prostate cancer
Johnson & Johnson has announced that its androgen receptor inhibitor apalutamide, now branded as Erleada, has received approval from the …
Astellas scoops up Universal Cells for $102.5m
February 15, 2018Sales and Marketing Astellas, Universal Cells, biotech, drugs, pharma, pharmaceutical
Astellas Pharma had only signed an exclusive licensing deal with Universal Cells back in October for the co-development of a …
Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation
February 14, 2018Research and Development KardiaMobile, NHS, atrial fibrillation, pharma
AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic …
New biotech facility to bring 350 jobs to Dublin
February 14, 2018Manufacturing and Production, Research and Development Dublin, Ireland, MSD, pharma
MSD has announced plans to invest in a new biotechnology facility in Dublin which it claims will create 350 jobs …
Lilly posts promising P3 Taltz data
February 14, 2018Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical
The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …
MSD shuts down Phase 3 trial in prodromal Alzheimer’s
February 14, 2018Research and Development Alzheimer's, MSD, pharma, verubecestat
Another blow has been dealt to the field of Alzheimer’s research as MSD announces yet another trial failure of a …
Pfizer taps real world evidence for CVD in new partnership
February 14, 2018Research and Development BC Platforms, Pfizer, biotech, cardiovascular disease, drugs, pharma, pharmaceutical
BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer …
Bill & Melinda Gates Foundation shows faith in CureVac
February 14, 2018Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical
The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
Roivant signs $600m licensing deal with Poxel
February 13, 2018Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma
Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …
Vertex gets approval for combo-therapy in cystic fibrosis
February 13, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …
Cancer-targeting nanorobots successfully starve and shrink tumours, study shows
February 13, 2018Manufacturing and Production, Research and Development Arizona State university, Cancer, Chinese Academy of Sciences, National Center for Nanoscience and Technology, nanorobots, pharma
A team of researchers from Arizona State University (ASU), in partnership with the Chinese Academy of Sciences’ National Center for …
Purdue pulls plug on opioid marketing
February 13, 2018Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical
Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …
New flu med can destroy influenza virus in one day
February 13, 2018Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical
Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …
Taking a look behind the scenes of Serialisation
February 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Serialization, biotech, drugs, pharma, pharmaceutical, serialisation
The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves discovers the challenges …
NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma
February 12, 2018Sales and Marketing Gazyvaro, NHS, NICE, Roche, follicular lymphoma
Roche has announced that NICE has issued its final decision to recommend the use of its Gazyvaro (obinutuzumab). The glyco-engineered …
Sanofi in $155m influenza vaccine deal
February 12, 2018Sales and Marketing SK Chemicals, Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi has revealed that it has agreed a deal with SK Chemicals, a South Korean vaccine manufacturer, to license its …
Novo’s Ozempic secures European approval in type 2 diabetes
February 12, 2018Sales and Marketing EC, EMA, Europe, Novo Nordisk, diabetes, pharma
Novo Nordisk has revealed that its drug Ozempic (semaglutide) has received approval from the European Commission (EC) as a monotherapy …
Trump’s drug pricing reforms lack bite
February 12, 2018Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical
President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
